Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Episteme Prognostics Logo
Episteme Prognostics Growth Score
36
CB Rank
68462
Heat Score
69
Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Founded
obfuscation
PrivateSeed New York, New York, United States www.epistemedx.com/
Biotechnology
Health Care
Health Diagnostics
Medical
Precision Medicine
Therapeutics
Overview

Episteme Prognostics
Total Funding
obfuscation
Growth Score
36
Heat Score
69

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score36
-33 pts
in past quarter
Heat Score 69
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Episteme Prognostics

CB Rank
68462
Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Founded
obfuscation
PrivateSeed New York, New York, United States www.epistemedx.com/
Biotechnology
Health Care
Health Diagnostics
Medical
Precision Medicine
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Episteme Prognostics, Inc.
Operating Status Active
Company Type For Profit
Founders  Steven Leach, Surajit Dhara
About the Company
Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It predicts chemotherapy response and assesses the benefit of epigenetic therapy to pancreatic cancer patients.
Contact Email info@epistemedx.com
Predictions & Insights

Research & Development

Episteme Prognostics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed
obfuscation
Seed Round - Episteme Prognostics Logo
Seed Round - Episteme Prognostics
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Employee Profiles 2

Employee Profiles

News

News and Press

News•Apr 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

2Episteme Prognostics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl.
Sub-Organizations
Frequently Asked Questions

Where is Episteme Prognostics's headquarters? Episteme Prognostics is located in New York, New York, United States.When was the last funding round for Episteme Prognostics? Episteme Prognostics closed its last funding round on
obfuscation
from a Seed round.Who are Episteme Prognostics's competitors? Alternatives and possible competitors to Episteme Prognostics may include Tempus, Caris Life Sciences, and  Freenome.How much funding has Episteme Prognostics raised to date? Episteme Prognostics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|